Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neeraj Shakya

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Bioorganic & Medicinal Chemistry|December 17, 2008
Substituted 1,2,3,4-tetrahydroquinolin-6-yloxypropanes as beta3-adrenergic receptor agonists: design, synthesis, biological evaluation and pharmacophore modelingNeeraj Shakya, Kuldeep K Roy, Anil K Saxena
Pharmaceuticals (Basel, Switzerland)|November 28, 2013
Chemotherapeutic interventions against tuberculosisNeeraj Shakya, Gaurav Garg, Babita Agrawal, et al.
Bioorganic & Medicinal Chemistry Letters|February 4, 2014
4'-Substituted pyrimidine nucleosides lacking 5'-hydroxyl function as potential anti-HCV agentsNeeraj Shakya, Satish Vedi, Chao Liang, et al.
Bioorganic & Medicinal Chemistry Letters|September 19, 2012
A new class of pyrimidine nucleosides: inhibitors of hepatitis B and C virusesNeeraj Shakya, Satish Vedi, Chao Liang, et al.
Bioorganic & Medicinal Chemistry|November 5, 2002
Development of 3D-QSAR models for 5-lipoxygenase antagonists: chalconesM Arockia Babu, Neeraj Shakya, Philip Prathipati, et al.
Journal of Medicinal Chemistry|April 28, 2010
3'-bromo analogues of pyrimidine nucleosides as a new class of potent inhibitors of Mycobacterium tuberculosisNeeraj Shakya, Naveen C Srivastav, Nancy Desroches, et al.
Bioorganic & Medicinal Chemistry|September 26, 2016
Investigation of C-5 alkynyl (alkynyloxy or hydroxymethyl) and/or N-3 propynyl substituted pyrimidine nucleoside analogs as a new class of antimicrobial agentsSaurabh Garg, Neeraj Shakya, Naveen C Srivastav, et al.
Journal of Medicinal Chemistry|September 23, 2010
Antiviral activity of various 1-(2'-deoxy-β-D-lyxofuranosyl), 1-(2'-fluoro-β-D-xylofuranosyl), 1-(3'-fluoro-β-D-arabinofuranosyl), and 2'-fluoro-2',3'-didehydro-2',3'-dideoxyribose pyrimidine nucleoside analogues against duck hepatitis B virus (DHBV) and human hepatitis B virus (HBV) replicationNaveen C Srivastav, Neeraj Shakya, Michelle Mak, et al.
Bioorganic & Medicinal Chemistry|September 28, 2010
Synthesis and in vitro antiviral activities of 3'-fluoro (or chloro) and 2',3'-difluoro 2',3'-dideoxynucleoside analogs against hepatitis B and C virusesNaveen C Srivastav, Neeraj Shakya, Michelle Mak, et al.
Bioorganic & Medicinal Chemistry Letters|December 20, 2011
Antimycobacterial activities of 5-alkyl (or halo)-3'-substituted pyrimidine nucleoside analogsNaveen C Srivastav, Neeraj Shakya, Sudha Bhavanam, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Bioorganic & Medicinal Chemistry|December 17, 2008
Substituted 1,2,3,4-tetrahydroquinolin-6-yloxypropanes as beta3-adrenergic receptor agonists: design, synthesis, biological evaluation and pharmacophore modelingNeeraj Shakya, Kuldeep K Roy, Anil K Saxena
Pharmaceuticals (Basel, Switzerland)|November 28, 2013
Chemotherapeutic interventions against tuberculosisNeeraj Shakya, Gaurav Garg, Babita Agrawal, et al.
Bioorganic & Medicinal Chemistry Letters|February 4, 2014
4'-Substituted pyrimidine nucleosides lacking 5'-hydroxyl function as potential anti-HCV agentsNeeraj Shakya, Satish Vedi, Chao Liang, et al.
Bioorganic & Medicinal Chemistry Letters|September 19, 2012
A new class of pyrimidine nucleosides: inhibitors of hepatitis B and C virusesNeeraj Shakya, Satish Vedi, Chao Liang, et al.
Bioorganic & Medicinal Chemistry|November 5, 2002
Development of 3D-QSAR models for 5-lipoxygenase antagonists: chalconesM Arockia Babu, Neeraj Shakya, Philip Prathipati, et al.
Journal of Medicinal Chemistry|April 28, 2010
3'-bromo analogues of pyrimidine nucleosides as a new class of potent inhibitors of Mycobacterium tuberculosisNeeraj Shakya, Naveen C Srivastav, Nancy Desroches, et al.
Bioorganic & Medicinal Chemistry|September 26, 2016
Investigation of C-5 alkynyl (alkynyloxy or hydroxymethyl) and/or N-3 propynyl substituted pyrimidine nucleoside analogs as a new class of antimicrobial agentsSaurabh Garg, Neeraj Shakya, Naveen C Srivastav, et al.
Journal of Medicinal Chemistry|September 23, 2010
Antiviral activity of various 1-(2'-deoxy-β-D-lyxofuranosyl), 1-(2'-fluoro-β-D-xylofuranosyl), 1-(3'-fluoro-β-D-arabinofuranosyl), and 2'-fluoro-2',3'-didehydro-2',3'-dideoxyribose pyrimidine nucleoside analogues against duck hepatitis B virus (DHBV) and human hepatitis B virus (HBV) replicationNaveen C Srivastav, Neeraj Shakya, Michelle Mak, et al.
Bioorganic & Medicinal Chemistry|September 28, 2010
Synthesis and in vitro antiviral activities of 3'-fluoro (or chloro) and 2',3'-difluoro 2',3'-dideoxynucleoside analogs against hepatitis B and C virusesNaveen C Srivastav, Neeraj Shakya, Michelle Mak, et al.
Bioorganic & Medicinal Chemistry Letters|December 20, 2011
Antimycobacterial activities of 5-alkyl (or halo)-3'-substituted pyrimidine nucleoside analogsNaveen C Srivastav, Neeraj Shakya, Sudha Bhavanam, et al.
Pageof 2